Latest CMPI reports update at 2023-12-23: 2022-Q12021-Q42021-Q1
Checkmate Pharmaceuticals logo

Checkmate Pharmaceuticals CMPI

$ 10.5 0.0%

Country

usaUSA

IPO year

2020

Industry

Biotechnology

Stock Exchange

NASDAQ GLOBAL

CEO

Mr. Barry A. Labinger

Employees in the company

21

Shares

21.6 M

Market Cap[1]

$ 231 M

EBITDA (LTM)

$ -64 M

P/E (LTM)

-3.56

P/S (LTM)

-

EPS (LTM)

-2.95

Other stocks of industry "Biotechnology"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.